These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33340078)

  • 21. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ; Lawrence I
    Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contact allergy in chronic eczematous lip dermatitis.
    Schena D; Fantuzzi F; Girolomoni G
    Eur J Dermatol; 2008; 18(6):688-92. PubMed ID: 18955202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of atopic eyelid disease using topical tacrolimus following corticosteroid discontinuation in a patient with open-angle glaucoma.
    Kymionis GD; Tsilimbaris MK; Iliaki OE; Christodoulakis E; Siganos CS; Pallikaris IG
    Cornea; 2004 Nov; 23(8):828-30. PubMed ID: 15502487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young children with moderate-to-severe atopic dermatitis can be treated safely and effectively with either topical tacrolimus or mild corticosteroids.
    Perälä M; Ahola M; Mikkola T; Pelkonen AS; Remitz A; Mäkelä MJ
    Acta Paediatr; 2020 Mar; 109(3):550-556. PubMed ID: 31483891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of cheilitis glandularis superimposed on oral lichen planus: successful palliative treatment with topical tacrolimus and pimecrolimus.
    Erkek E; Sahin S; Kilic R; Erdogan S
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):999-1000. PubMed ID: 17659026
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group.
    Reitamo S; Wollenberg A; Schöpf E; Perrot JL; Marks R; Ruzicka T; Christophers E; Kapp A; Lahfa M; Rubins A; Jablonska S; Rustin M
    Arch Dermatol; 2000 Aug; 136(8):999-1006. PubMed ID: 10926735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids.
    Poole CD; Chambers C; Allsopp R; Currie CJ
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):674-8. PubMed ID: 20565562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis.
    Bekersky I; Fitzsimmons W; Tanase A; Maher RM; Hodosh E; Lawrence I
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S17-27. PubMed ID: 11145792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA Repair Enzyme Containing Lip Balm for the Treatment of Actinic Cheilitis: A Pilot Study.
    Rosenthal A; Lyons A; Moy L; Wilson A; Mohamadi K; Herrmann J; Tung R
    J Drugs Dermatol; 2019 Jun; 18(6):576. PubMed ID: 31251551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spotlight on topical pimecrolimus in atopic dermatitis.
    Wellington K; Jarvis B
    Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and management of exfoliative cheilitis: a single-center experience.
    Almazrooa SA; Woo SB; Mawardi H; Treister N
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Dec; 116(6):e485-9. PubMed ID: 24237731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term safety of tacrolimus ointment in atopic dermatitis.
    Remitz A; Reitamo S
    Expert Opin Drug Saf; 2009 Jul; 8(4):501-6. PubMed ID: 19435404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis.
    Sugiura H; Uehara M; Hoshino N; Yamaji A
    Br J Dermatol; 2001 Nov; 145(5):795-8. PubMed ID: 11736904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory Trial.
    Vives R; Pontes C; Sarasa M; Millier A
    Clin Ther; 2015 Sep; 37(9):1955-65. PubMed ID: 26163200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.